Clinical Trials

NCT02839707 | ACTIVE_NOT_RECRUITING | PHASE2/PHASE3
444 participants

Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-01
Start Date:
2017-06-23
Completion:
2023-05-09
Conditions
  • Fallopian Tube High Grade Serous Adenocarcinoma
  • Ovarian High Grade Serous Adenocarcinoma
  • Ovarian Seromucinous Carcinoma
  • Primary Peritoneal High Grade Serous Adenocarcinoma
  • Recurrent Fallopian Tube Carcinoma
  • Recurrent Fallopian Tube Clear Cell Adenocarcinoma
  • Recurrent Fallopian Tube Endometrioid Adenocarcinoma
  • Recurrent Fallopian Tube Undifferentiated Carcinoma
  • Recurrent Ovarian Carcinoma
  • Recurrent Ovarian Clear Cell Adenocarcinoma
  • Recurrent Ovarian Endometrioid Adenocarcinoma
  • Recurrent Ovarian Undifferentiated Carcinoma
  • Recurrent Platinum-Resistant Fallopian Tube Carcinoma
  • Recurrent Platinum-Resistant Ovarian Carcinoma
  • Recurrent Platinum-Resistant Primary Peritoneal Carcinoma
  • Recurrent Primary Peritoneal Carcinoma
  • Recurrent Primary Peritoneal Clear Cell Adenocarcinoma
  • Recurrent Primary Peritoneal Endometrioid Adenocarcinoma
  • Recurrent Primary Peritoneal Undifferentiated Carcinoma
Interventions
  • DRUG
  • BIOLOGICAL
  • PROCEDURE
  • OTHER
NCT02445391 | ACTIVE_NOT_RECRUITING | PHASE3
415 participants

Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-01
Start Date:
2015-10-20
Completion:
2021-04-07
Conditions
  • Estrogen Receptor Negative
  • HER2/Neu Negative
  • Invasive Breast Carcinoma
  • Progesterone Receptor Negative
  • Stage II Breast Cancer
  • Stage IIA Breast Cancer
  • Stage IIB Breast Cancer
  • Stage III Breast Cancer
  • Stage IIIA Breast Cancer
  • Stage IIIB Breast Cancer
  • Stage IIIC Breast Cancer
  • Triple-Negative Breast Carcinoma
Interventions
  • DRUG
NCT02423070 | RECRUITING
991 participants

Genome Transplant Dynamics

Study Type:
OBSERVATIONAL
Last Updated:
2026-06-01
Start Date:
2015-06-25
Completion:
2034-11-30
Conditions
  • Thoracic Organ Transplantation
No Results Yet
NCT02417740 | RECRUITING
400 participants

Natural History of Noncirrhotic Portal Hypertension

Study Type:
OBSERVATIONAL
Last Updated:
2026-06-01
Start Date:
2015-07-27
Completion:
2029-09-04
Conditions
  • Cystic Fibrosis
  • Immunologic Deficiency Syndrome
  • Turner Syndrome
  • Congenital Hepatic Fibrosis
  • Idiopathic Non-Cirrhotic Portal Hypertension
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page